Pharmacy rules by state
Pharmacy is regulated state by state. These guides cover the rules that change what a cash-paying patient can do: generic substitution, moving a prescription, controlled substances, what a pharmacist may prescribe, insulin caps, and veterinary prescriptions. Each cites the state board, and each says when it was last checked.
- Alabama
Alabama allows generic substitution unless the prescriber indicates the brand is medically necessary, schedules gabapentin as a controlled substance, requires a check of its monitoring program before many controlled prescriptions, has a naloxone standing order, and caps insulin cost-sharing on state-regulated plans.
- Alaska
Alaska limits first opioid prescriptions to a seven-day supply, requires a check of its monitoring program before many controlled prescriptions, does not let pharmacists prescribe contraception, and had no state insulin cap in force when this guide was checked.
- Arizona
Arizona allows generic substitution unless the prescriber marks dispense as written, limits first opioid prescriptions to five days, requires opioid prescriptions to be electronic, has a naloxone standing order, and had no state insulin cap in force when this guide was checked.
- Arkansas
Arkansas lets pharmacists provide the pill and emergency contraception to adults under a statewide protocol, requires prescribers to check its monitoring program before opioid and benzodiazepine prescriptions, limits initial opioid prescriptions for acute pain, and had no state insulin cap in force when this guide was checked.
- California
California lets a pharmacist substitute a generic equivalent unless the prescriber forbids it, requires almost all prescriptions to be sent electronically, and lets pharmacists furnish some medicines directly under board protocols, including hormonal contraception, naloxone and HIV prevention medicines.
- Colorado
Colorado allows generic substitution unless the prescriber writes dispense as written, caps insulin cost-sharing on state-regulated plans, lets pharmacists prescribe contraception and treat some minor conditions, and requires a check of its monitoring program before many controlled prescriptions.
- Connecticut
Connecticut caps cost-sharing for insulin and other diabetes medicines on state-regulated plans, lets pharmacists prescribe hormonal contraception, requires controlled-substance prescriptions to be electronic, limits first opioid prescriptions, and regulates pharmacy through a commission within the Department of Consumer Protection.
- Delaware
Delaware caps insulin and diabetes-supply cost-sharing on state-regulated plans, with insulin pumps covered at no cost-sharing, lets pharmacists provide hormonal contraception under a standing order, and requires a check of its monitoring program before many controlled prescriptions.
- Florida
Florida requires pharmacists to substitute a less expensive generic equivalent unless the prescriber writes that the brand is medically necessary, lets patients refuse the substitution, allows pharmacists to test and treat some minor conditions, and runs a prescription monitoring program that must be checked for most controlled substances.
- Georgia
Georgia allows generic substitution unless the prescriber writes that the brand is necessary, requires a check of the state prescription monitoring program before many controlled prescriptions, has a naloxone standing order, and had no state insulin cap in force when this guide was checked.
- Hawaii
Hawaii lets pharmacists prescribe hormonal contraception, allows generic substitution unless the prescriber indicates otherwise, monitors controlled prescriptions through its Narcotics Enforcement Division, and had no state insulin cap in force when this guide was checked.
- Idaho
Idaho gives pharmacists independent prescribing authority for some medicines, including hormonal contraception, allows generic substitution unless the prescriber indicates otherwise, and had no state insulin cap in force when this guide was checked.
- Illinois
Illinois allows generic substitution unless the prescriber indicates the brand is required, caps insulin cost-sharing on state-regulated plans, requires controlled-substance prescriptions to be electronic, and regulates pharmacy through the Department of Financial and Professional Regulation.
- Indiana
Indiana allows generic substitution unless the prescriber writes brand medically necessary, requires controlled-substance prescriptions to be electronic, reports gabapentin to its monitoring program, lets pharmacists prescribe hormonal contraception under a recent law, and had no state insulin cap in force when this guide was checked.
- Iowa
Iowa gave pharmacists independent authority to prescribe hormonal contraception in 2025, requires controlled-substance prescriptions to be electronic, requires prescribers to register with and use its monitoring program, and had no state insulin cap in force when this guide was checked.
- Kansas
Kansas allows generic substitution unless the prescriber indicates the brand is required, runs the K-TRACS monitoring program through its Board of Pharmacy, does not let pharmacists prescribe contraception, and had no state insulin cap in force when this guide was checked.
- Kentucky
Kentucky schedules gabapentin as a controlled substance, limits most first opioid prescriptions for acute pain to three days, runs the KASPER monitoring program, caps insulin cost-sharing on state-regulated plans, and allows generic substitution unless the prescriber indicates otherwise.
- Louisiana
Louisiana allows generic substitution unless the prescriber indicates the brand is required, limits first opioid prescriptions for acute pain to seven days, requires a check of its monitoring program before many controlled prescriptions, caps insulin cost-sharing on state-regulated plans, and does not let pharmacists prescribe contraception.
- Maine
Maine sets statutory limits on opioid prescribing, caps insulin cost-sharing on state-regulated plans, has authorized pharmacist-prescribed contraception, and allows generic substitution unless the prescriber indicates otherwise.
- Maryland
Maryland allows generic substitution unless the prescriber writes dispense as written, runs a prescription monitoring program that must be checked before many controlled prescriptions, lets pharmacists prescribe contraception, and caps insulin cost-sharing on state-regulated plans.
- Massachusetts
Massachusetts requires generic substitution unless the prescriber writes no substitution, has required all prescriptions to be electronic since 2021, limits first opioid prescriptions to seven days, reports gabapentin to its monitoring program, and caps insulin cost-sharing on state-regulated plans.
- Michigan
Michigan allows generic substitution unless the prescriber writes dispense as written, has required almost all prescriptions to be electronic since January 2023, schedules gabapentin as a controlled substance, and limits first opioid prescriptions for acute pain.
- Minnesota
Minnesota allows generic substitution unless the prescriber writes dispense as written, caps cost-sharing for insulin and other diabetes medicines on state-regulated plans and runs an insulin safety-net program, lets pharmacists prescribe contraception under a statewide protocol, and requires a check of its monitoring program for many controlled prescriptions.
- Mississippi
Mississippi allows generic substitution unless the prescriber indicates the brand is required, runs a prescription monitoring program through its Board of Pharmacy, does not let pharmacists prescribe contraception, and had no state insulin cap in force when this guide was checked.
- Missouri
Missouri allows generic substitution unless the prescriber writes dispense as written, authorized a statewide prescription monitoring program in 2021, limits first opioid prescriptions to seven days, has a naloxone standing order, and had no state insulin cap in force when this guide was checked.
- Montana
Montana gives pharmacists prescriptive authority for hormonal contraception, caps insulin cost-sharing on state-regulated plans, requires a check of its monitoring program before many controlled prescriptions, and allows generic substitution unless the prescriber indicates otherwise.
- Nebraska
Nebraska runs a prescription monitoring program that records every dispensed prescription, not just controlled substances, caps insulin cost-sharing on state-regulated plans, and lets pharmacists provide hormonal contraception under collaborative practice agreements.
- Nevada
Nevada lets pharmacists prescribe hormonal contraception under a statewide protocol, caps insulin cost-sharing on state-regulated plans under a 2025 law, limits initial opioid prescriptions for acute pain, and requires prescribers to check its monitoring program before many controlled prescriptions.
- New Hampshire
New Hampshire caps insulin cost-sharing on state-regulated plans, has authorized pharmacist-provided contraception under a statewide protocol, requires a check of its monitoring program before many opioid prescriptions, and regulates pharmacy through the Office of Professional Licensure and Certification.
- New Jersey
New Jersey requires generic substitution unless the prescriber marks do not substitute, has moved to electronic prescribing, limits first opioid prescriptions to five days, caps insulin and some other cost-sharing on state-regulated plans, and lets pharmacists provide hormonal contraception under a recent law.
- New Mexico
New Mexico gives pharmacists prescribing authority, including a pharmacist clinician license and a statewide protocol for contraception, caps insulin cost-sharing on state-regulated plans, and requires a check of its monitoring program before many controlled prescriptions.
- New York
New York requires generic substitution unless the prescriber signs the dispense-as-written box, has required almost all prescriptions to be electronic since 2016, and has eliminated insulin cost-sharing on state-regulated plans. Pharmacy is regulated by the State Education Department’s Office of the Professions rather than a stand-alone board.
- North Carolina
North Carolina allows generic substitution unless the prescriber indicates the brand is medically necessary, limits first opioid prescriptions under the STOP Act, requires controlled-substance prescriptions to be electronic, and lets pharmacists prescribe hormonal contraception under a statewide protocol.
- North Dakota
North Dakota law generally requires a pharmacy to be majority-owned by licensed pharmacists, with some exceptions. It schedules gabapentin as a controlled substance, caps insulin cost-sharing under a 2025 law, and does not let pharmacists prescribe contraception.
- Ohio
Ohio lets a pharmacist substitute a generic unless the prescriber writes dispense as written, runs the OARRS prescription monitoring program, limits first opioid prescriptions for acute pain, requires gabapentin dispensing to be reported, and had no state insulin cap in force when this guide was checked.
- Oklahoma
Oklahoma allows generic substitution unless the prescriber indicates the brand is required, limits first opioid prescriptions for acute pain to seven days, requires opioid prescriptions to be electronic, caps insulin cost-sharing on state-regulated plans, and does not let pharmacists prescribe contraception.
- Oregon
Oregon has let pharmacists prescribe hormonal contraception since 2016, allows generic substitution unless the prescriber marks no substitution, caps insulin cost-sharing on state-regulated plans, and gives pharmacists prescribing authority for a defined list of medicines and services.
- Pennsylvania
Pennsylvania lets a pharmacist substitute a generic unless the prescriber writes that the brand is medically necessary, requires controlled-substance prescriptions to be electronic, has no state insulin cap in force, and regulates pharmacy through a board under the Department of State.
- Rhode Island
Rhode Island caps insulin cost-sharing on state-regulated plans, has authorized pharmacist-provided contraception under a statewide protocol, sets detailed limits on first opioid prescriptions, and regulates pharmacy through the Department of Health.
- South Carolina
South Carolina allows generic substitution unless the prescriber indicates the brand is medically necessary, requires a check of its monitoring program before many controlled prescriptions, limits first opioid prescriptions for acute pain, lets pharmacists prescribe contraception under a recent law, and had no state insulin cap in force when this guide was checked.
- South Dakota
South Dakota lets pharmacists provide hormonal contraception and other drug therapy under collaborative practice agreements, runs a prescription monitoring program through its Board of Pharmacy, allows generic substitution unless the prescriber indicates otherwise, and had no state insulin cap in force when this guide was checked.
- Tennessee
Tennessee allows generic substitution unless the prescriber indicates the brand is medically necessary, schedules gabapentin as a controlled substance, requires controlled-substance prescriptions to be electronic, limits first opioid prescriptions for acute pain, and had no state insulin cap in force when this guide was checked.
- Texas
Texas allows generic substitution unless the prescriber writes that the brand is necessary, requires controlled-substance prescriptions to be electronic, caps insulin cost-sharing on state-regulated plans, and has a board of pharmacy with a straightforward public license lookup.
- Utah
Utah lets pharmacists provide hormonal contraception to adults under a standing order, caps insulin cost-sharing on state-regulated plans and allows emergency insulin refills, limits first opioid prescriptions for acute pain to seven days, and regulates pharmacy through the Division of Professional Licensing.
- Vermont
Vermont lets pharmacists provide hormonal contraception under a statewide protocol, caps total insulin cost-sharing on state-regulated plans, sets opioid prescribing limits by the severity of pain, and regulates pharmacy through the Office of Professional Regulation.
- Virginia
Virginia allows generic substitution unless the prescriber writes brand medically necessary, schedules gabapentin as a controlled substance, requires opioid prescriptions to be electronic, limits first opioid prescriptions for acute pain, and caps insulin cost-sharing on state-regulated plans.
- Washington
Washington allows generic substitution unless the prescriber marks dispense as written, caps insulin cost-sharing on state-regulated plans, gives pharmacists prescribing authority under collaborative agreements, and regulates pharmacy through a commission rather than a board.
- West Virginia
West Virginia schedules gabapentin as a controlled substance, limits first opioid prescriptions to a few days’ supply depending on the setting, lets pharmacists provide contraception to adults under a standing order, and caps insulin and diabetes-supply cost-sharing on state-regulated plans.
- Wisconsin
Wisconsin allows generic substitution unless the prescriber indicates the brand is required, requires a check of its prescription monitoring program before most controlled prescriptions, has a naloxone standing order, and had no state insulin cap in force when this guide was checked.
- Wyoming
Wyoming allows generic substitution unless the prescriber indicates otherwise, runs a prescription monitoring program through its Board of Pharmacy, does not let pharmacists prescribe contraception, and had no state insulin cap in force when this guide was checked.
- District of Columbia
The District of Columbia caps insulin and diabetes-device cost-sharing on plans it regulates, has authorized pharmacist-provided contraception under a protocol, runs its own prescription monitoring program through DC Health, and allows generic substitution unless the prescriber indicates otherwise.